@article{Ewa Lech-Maranda_Przemyslaw Juszczynski_Anna Szmigielska-Kaplon_Krzysztof Jamroziak_Ewa Balcerczak_Tadeusz Robak_2007, place={Pavia, Italy}, title={Human leukocyte antigens HLA DRB1 influence clinical outcome of chronic lymphocytic leukemia}, volume={92}, url={https://haematologica.org/article/view/4451}, DOI={10.3324/haematol.10910}, abstractNote={We investigated HLA DRB1 correlations with chronic lymphocytic leukemia (B-CLL) outcome in 90 patients. Neither of the alleles was associated with B-CLL clinical characteristics or mortality. HLA DRB1*01 and HLA DRB1*02-null were associated with shorter overall survival (<em>p</em>=0.007, <em>p</em&gt;=0.002). Our results suggest that HLA-restricted adaptive immunity influences CLL outcome.}, number={5}, journal={Haematologica}, author={Ewa Lech-Maranda and Przemyslaw Juszczynski and Anna Szmigielska-Kaplon and Krzysztof Jamroziak and Ewa Balcerczak and Tadeusz Robak}, year={2007}, month={May}, pages={710-711} }